NASDAQ:PRPO

Precipio (PRPO) Stock Price, News & Analysis

Precipio logo
$19.17 -0.79 (-3.96%)
Closing price 11/17/2026 04:00 PM Eastern
Extended Trading
$19.19 +0.02 (+0.11%)
As of 04:14 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Precipio Stock (NASDAQ:PRPO)

Advanced

Key Stats

Today's Range
$18.45
▼
$21.19
50-Day Range
$17.79
▼
$27.32
52-Week Range
$17.79
▼
$33.63
Volume
46,287 shs
Average Volume
26,838 shs
Market Capitalization
$34.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Precipio is a diagnostics company focused on hematologic cancers and other complex diseases. It provides specialized pathology and laboratory testing services to help physicians identify and characterize blood disorders and malignancies.

The company also develops and sells diagnostic products for use by clinical laboratories. Its HemeScreen platform offers molecular testing for genetic mutations associated with blood cancers, while its broader product offerings support laboratories seeking to perform specialized diagnostic tests.

Precipio operates a clinical laboratory in New Haven, Connecticut, and serves healthcare providers and laboratories through its testing services and diagnostic products. Its business combines direct laboratory services with products designed for use by other testing facilities.

AI Generated. May Contain Errors.

Precipio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
13th Percentile Overall Score

PRPO MarketRank™: 
0.66493263972 of 5 stars

Precipio scored higher than 13% of companies evaluated by MarketBeat, and ranked 822nd out of 859 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Precipio has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Precipio has only been the subject of 1 research reports in the past 90 days.

  • Read more about Precipio's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Precipio is -32.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Precipio is -32.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Precipio has a P/B Ratio of 2.31. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    3.68% of the float of Precipio has been sold short.
  • Short Interest Ratio / Days to Cover

    Precipio has a short interest ratio ("days to cover") of 1.47, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Precipio has recently decreased by 6.73%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Precipio does not currently pay a dividend.

  • Dividend Growth

    Precipio does not have a long track record of dividend growth.

  • News Sentiment

    Precipio has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Precipio this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Precipio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    16.60% of the stock of Precipio is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    10.45% of the stock of Precipio is held by institutions.

  • Read more about Precipio's insider trading history.
Receive PRPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Precipio and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PRPO Stock News Headlines

Precipio Announces Q3-2026 Financial Results
Precipio (PRPO) Q3 2026 Earnings Call Transcript
What the hell is going on?
Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.tc pixel
Precipio Announces Q3-2026 Financial Results
Precipio Announces Q3 2026 Shareholder Update Call
Precipio Announces Q3-2026 Shareholder Update Call
Precipio Announces Q3-2026 Shareholder Update Call
See More Headlines

PRPO Stock Analysis - Frequently Asked Questions

Precipio's stock was trading at $22.98 at the beginning of 2026. Since then, PRPO shares have decreased by 16.6% and is now trading at $19.17.

Precipio, Inc. (NASDAQ:PRPO) posted its earnings results on Friday, August, 14th. The biotechnology company reported ($0.12) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.00) by $1.88. The biotechnology company had revenue of $7.02 million for the quarter, compared to analyst estimates of $1.68 million. Precipio had a negative net margin of 4.12% and a negative trailing twelve-month return on equity of 7.84%.
Read the conference call transcript
.

Precipio's stock reverse split before market open on Friday, September 22nd 2023.The 1-20 reverse split was announced on Friday, September 22nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, September 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of PRPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Precipio investors own include Jaguar Animal Health (JAGX), iBio (IBIO), FuelCell Energy (FCEL), Gevo (GEVO), VBI Vaccines (VBIV), Sorrento Therapeutics (SRNE) and ADMA Biologics (ADMA).

Company Calendar

Last Earnings
8/14/2026
Today
11/18/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NASDAQ:PRPO
CIK
1043961
Employees
71
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.59)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$360 thousand
Net Margins
-4.12%
Pretax Margin
-4.12%
Return on Equity
-7.84%
Return on Assets
-5.37%

Debt

Debt-to-Equity Ratio
0.06
Current Ratio
1.77
Quick Ratio
1.54

Sales & Book Value

Annual Sales
$24.05 million
Price / Sales
1.43
Cash Flow
$0.76 per share
Price / Cash Flow
25.12
Book Value
$8.29 per share
Price / Book
2.31

Miscellaneous

Outstanding Shares
1,790,000
Free Float
1,495,000
Market Cap
$34.31 million
Optionable
No Data
Beta
1.45
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

This page (NASDAQ:PRPO) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners